November 15, 2018 Vol. 38, No. 20
GEN's supplement "Biobanking Integrity" discusses the kinds of work carried out by biobanks. This supplement describes how biobanks are improving, but also conveys that biobanking is also about faith.
Banking is about generating returns. In a biobank yield returns in the form of scientific dividends. In research, investment equates to both the quality of samples and the manner in which they are stored.
Improvements in our understanding of disease have relied primarily on clinical trials backed by real-world evidence. Biological samples and large-scale datasets are key components...
Since 2013, when I was invited to speak about biobanking economics at the Annual Biobank China conference in Shanghai, I have worked as a...
Sponsored by When considering the purchase of automated equipment, including automated sample storage systems, users typically start with a focus on today’s business needs. How...
Clinical Supplies Management (CSM) has spent the last two decades partnering with research groups that want peace of mind when it comes to storing their irreplaceable biological samples.
GEN recently interviewed Bill Mathieson, Ph.D. and Rainer Nitsche, Ph.D. about the various issues and factors impacting biobanking operations and instrumentation, including the Agilent TapeStation systems.
Sponsored by Moderated by Andrew Brooks, Ph.D. Dr. Brooks: Let’s start the discussion with an eye on both research and clinical use of biological samples. Are...
Short stories on multicellular structures, placenta genes, and sepsis.
Europe's biotech industry recently celebrated its growth and progress.
There’s nothing ponderous about Mammoth Biosciences. The company is charging ahead, enhancing its CRISPR-based diagnostic platform, which can “Google” genes implicated in human diseases.
According to Dotmatics, objective analysis of complex and high-dimensional data can inform design changes, cycle by cycle, refining sequence-based structures and optimizing drug leads.
BrainXell describes how differentiating large numbers of neurons from patient-derived induced pluripotent stem cells can improve the relevance of drug screens.
Continuous processing means real-time monitoring process analytical technology, and enhanced chromatographic techniques—such as the IEX and SEC techniques described by Phenomenex.